Bridge Pharma (United States)
In research, Bridge Pharma (United States) stands highest in Health Sciences (#11,797 of 20,462 worldwide) and Medicine (#10,822 of 17,978 worldwide), over all time.
- World rank, 2022–2025
- #15,011 of 28,054 · #19,673 all time
- Rank in United States
- #2,111 of 4,192
- Research works
- 420 ▲ 27% vs 2013–17
- Citations
- 5.5k 13.1 per fractional work
- Top-10% rate
- 12.3% record average 16.5%
- Open access
- 37% world 28%
What is Bridge Pharma (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #11,797 of 20,462 | 15.3% | 154 | |
| MedicineField | #10,822 of 17,978 | 13.6% | 135 |
Each strip is that field’s whole ranked pool, with the notch where Bridge Pharma (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 4.8×
- Immunology and Microbiology 3.5×
- Nursing 2.7×
- Neuroscience 2.5×
- Chemistry 2.3×
- Biochemistry, Genetics and Molecular Biology 2.3×
- Medicine 1.8×
- Engineering 1.0×
- Dentistry 0.7×
- Computer Science 0.7×
- Business, Management and Accounting 0.6×
- Health Professions 0.6×
- Psychology 0.6×
- Earth and Planetary Sciences 0.5×
- Environmental Science 0.4×
- Social Sciences 0.4×
- Materials Science 0.4×
- Chemical Engineering 0.3×
- Economics, Econometrics and Finance 0.3×
- Energy 0.3×
- Agricultural and Biological Sciences 0.2×
- Arts and Humanities 0.2×
- Decision Sciences 0.1×
- Physics and Astronomy 0.0×
Who are the top researchers at Bridge Pharma (United States)?
Ranked on the composite score, Hermann AM Mucke and Fredric J. Cohen lead among researchers whose main affiliation is Bridge Pharma (United States).
- 1 Hermann AM Mucke United States · #1,170,531 worldwide 34 citations · 105 works
- 2 Fredric J. Cohen United States · #1,509,900 worldwide 12 citations · 18 works
Which keywords describe research at Bridge Pharma (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Treatment, Dynamic Interaction, Prognosis, Chronic Kidney Disease, Diagnosis, Thrombosis, Footbridges and Vibration Serviceability.
- Immune Activation
- Regulatory T Cells
- Glycosylation
- phosphate
- Lymphoma
- Innate Immunity
- Parathyroid Hormone
- Pharmacokinetics
- Hereditary Angioedema
- Neurological Disorders
- Myelofibrosis
- JAK2 Mutation
- Cardiac Amyloidosis
- Depression
- Drug Discovery
- Thrombosis
- Prognosis
- Chronic Kidney Disease
- Diagnosis
- Treatment
- Epidemiology
- Inflammation
- Dynamic Interaction
- Clinical Trials
- Footbridges
- Vibration Serviceability
- Cancer
- Neuroinflammation
- Transthyretin
- Medicinal Chemistry
- Cancer Therapy
- Immune Response
- Kinin Receptor Family
- Neuroprotection
- Cytokines
- FGF23
- TGF-ß
- Emotions
- Interstitial Lung Disease
- Schizophrenia
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology5▲ 1.21×35 topics
- Treatment5▲ 3.7×14 topics
- Inflammation4▲ 1.93×21 topics
- Diagnosis4▲ 4.0×11 topics
- Dynamic Interaction3▲ 44×2 topics
- Chronic Kidney Disease3▲ 12×5 topics
- Clinical Trials3▲ 4.1×10 topics
- Prognosis3▲ 8.7×5 topics
- Footbridges3▲ 64×1 topic
- Thrombosis3▲ 9.1×3 topics
- Vibration Serviceability3▲ 64×1 topic
- Drug Discovery2▲ 11×4 topics
- Cancer2▲ 1.77×17 topics
- Depression2▲ 2.6×10 topics
- Neuroinflammation2▲ 8.3×5 topics
- Cardiac Amyloidosis2▲ 107×1 topic
- Transthyretin2▲ 107×1 topic
- JAK2 Mutation2▲ 90×1 topic
- Medicinal Chemistry2▲ 7.8×5 topics
- Myelofibrosis2▲ 90×1 topic
- Cancer Therapy2▲ 3.6×9 topics
- Neurological Disorders2▲ 3.5×8 topics
- Immune Response2▲ 3.1×11 topics
- Hereditary Angioedema2▲ 91×1 topic
- Kinin Receptor Family2▲ 91×1 topic
- Pharmacokinetics2▲ 6.4×4 topics
- Neuroprotection2▲ 4.5×6 topics
- Parathyroid Hormone2▲ 17×2 topics
- Cytokines2▲ 5.2×3 topics
- Innate Immunity2▲ 4.7×5 topics
- FGF231▲ 41×1 topic
- Lymphoma1▲ 8.1×3 topics
- TGF-ß1▲ 9.2×3 topics
- phosphate1▲ 41×1 topic
- Emotions1▲ 28×2 topics
- Glycosylation1▲ 12×3 topics
- Interstitial Lung Disease1▲ 20×2 topics
- Regulatory T Cells1▲ 11×3 topics
- Schizophrenia1▲ 10×2 topics
- Immune Activation1▲ 14×2 topics
Which research topics does Bridge Pharma (United States) publish most on?
By volume in 2022–2025: Structural Engineering and Vibration Analysis, Amyloidosis: Diagnosis, Treatment, Outcomes, Myeloproliferative Neoplasms: Diagnosis and Treatment and Coagulation, Bradykinin, Polyphosphates, and Angioedema.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Structural Engineering and Vibration Analysis Civil and Structural Engineering 3 works
- 2 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 2 works
- 3 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
- 4 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 2 works
- 5 Parathyroid Disorders and Treatments Nephrology 1 works
- 6 Tryptophan and brain disorders Biological Psychiatry 1 works
- 7 Pain Mechanisms and Treatments Physiology 1 works
- 8 Chemical Reactions and Isotopes Pharmaceutical Science 1 works
- 9 Click Chemistry and Applications Organic Chemistry 1 works
- 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Bridge Pharma (United States)'s research output changed?
Output in 2018–2022 was 27% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Sarasota
- New College of Florida
- University of South Florida Sarasota–Manatee
- Mote Marine Laboratory
- Professional Services Group (United States)
- Sarasota University
- Sarasota Memorial Hospital
- American Accounting Association
- Roskamp Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.